SynthesisMedicine2016

Adverse events risk associated with anti-VEGFR agents in the treatment of advanced nonsmall-cell lung cancer: A meta-analysis.

Biao Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.